Bausch Health Companies Inc.
BHC
$6.25
-$0.07-1.11%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.80% | 7.01% | 8.41% | 9.87% | 10.92% |
| Total Other Revenue | 10.78% | 18.18% | 19.79% | 13.83% | 9.68% |
| Total Revenue | 5.86% | 7.13% | 8.53% | 9.91% | 10.91% |
| Cost of Revenue | 6.59% | 7.48% | 8.64% | 8.71% | 10.14% |
| Gross Profit | 5.56% | 6.98% | 8.49% | 10.41% | 11.23% |
| SG&A Expenses | 4.14% | 10.46% | 12.87% | 13.07% | 15.42% |
| Depreciation & Amortization | -6.91% | -3.15% | -1.76% | 0.00% | -0.72% |
| Other Operating Expenses | -- | -- | -- | -- | -100.00% |
| Total Operating Expenses | 3.46% | 6.55% | 8.03% | 8.59% | 9.78% |
| Operating Income | 16.27% | 9.62% | 10.71% | 15.79% | 16.08% |
| Income Before Tax | 1,161.22% | 179.38% | 158.51% | 142.82% | 93.38% |
| Income Tax Expenses | 18.45% | 52.29% | 73.08% | 8.14% | -28.21% |
| Earnings from Continuing Operations | 247.93% | 109.47% | 83.09% | 88.22% | 77.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.13% | 38.89% | 70.83% | 36.84% | 254.55% |
| Net Income | 303.37% | 120.81% | 91.21% | 92.23% | 81.52% |
| EBIT | 16.27% | 9.62% | 10.71% | 15.79% | 16.08% |
| EBITDA | 7.34% | 4.64% | 5.67% | 8.95% | 8.50% |
| EPS Basic | 298.52% | 120.24% | 91.15% | 92.13% | 81.56% |
| Normalized Basic EPS | 33.98% | 29.96% | 73.55% | 71.28% | 66.38% |
| EPS Diluted | 298.52% | 120.24% | 91.16% | 92.14% | 81.58% |
| Normalized Diluted EPS | 34.13% | 30.13% | 73.54% | 71.27% | 66.36% |
| Average Basic Shares Outstanding | 2.08% | 1.80% | 1.82% | 1.87% | 0.09% |
| Average Diluted Shares Outstanding | 2.07% | 1.80% | 1.81% | 1.87% | 0.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |